Hydroxy-urea and Temozolomide in Patients With a Recurrent Malignant Brain Tumor (Glioblastoma)
Clinical trial NCT03463733 · UNKNOWN
Trial details
- NCT number
- NCT03463733
- Sponsor
- M.E. van Linde
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-02
- Primary completion
- 2021-06-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.